药物诱导性肝损伤生物标志物研究进展

doi:10.3969/j.issn.1672-5069.2014.06.002

Abstract

Yu Yuecheng, He Changlun, Hou Jinlin. Biomarkers in drug-induced liver injuries[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(6): 564-569.

[1] Watkins PB. Biomarkers for drug-induced liver injury. In: Kaplowitz N,Deleve LD. Drug-induced liver disease,3rd ed. San Diego:Academic Press,2013: 275-286.
[2] Watkins PB,Seligman PJ,Pears JS,et al. Using controlled clinicaltrials to learn more about acute drug-induced liver injury. Hepatology,2008,48（5）:1680-1689.
[3] Daly AK,Day CP. Genetic factors in the pathogenesis of drug-induced liver injury. In:Kaplowitz N,Deleve LD. Drug-induced liver disease,3rd ed. San Diego:Academic Press,2013:215-225.
[4] Olson S,Robinson S,Giffin R. Accelerating the development of biomarkers for drug safety:Workshop summary. http://wwwiomedu/Reports/2009/BiomarkersDrugSafetyaspx.
[5] Jones DP,Lemasters JJ,Han D, et al. Mechanisms of pathogenesis in drug hepatotoxicity putting thestress on mitochondria. Mol Interv,2010,10（2）:98-111.
[6] Daly AK,Day CP. Genetic association studies in drug-induced liver injury. Drug Metab Rev,2012,44（1）:116-126.
[7] Chalasani NP,Hayashi PH,Bonkovsky HL,et al. ACG clinical guideline:The diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol,2014,109（7）:950-966.
[8] Radi ZA,Koza-Taylor PH,Bell RR,et al. Increased serumenzyme levels associated with Kupffer cell reduction with nosigns of hepatic or skeletal muscle injury. Am J Pathol,2011,179（1）:240-247.
[9] Thulin P,Rafter I,Stockling K,et al. PPARalpha regulates thehepatotoxic biomarker alanine aminotransferase （ALT1） geneexpression in human hepatocytes. Toxicol Appl Pharmacol,2008,231（1）:1-9.
[10] Guidance for Industry: Drug-induced liver injury: PremarketingClinical Evaluation. 2009. （http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM174090.pdf）.
[11] 胡锡祺. 药物性肝损伤组织病理学评分探讨. 中华肝脏病杂志,2012,20（3）:176-177.
[12] Rockey DC,Seeff LB,Rochon J,et al. Causality assessment in drug-induced liver injury usinga structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method. Hepatology,2010,51（6）:2117-2126.
[13] Fannin RD,Russo M,O'Connell TM,et al. Acetaminophen dosing of humans results in blood transcriptome and metabolomechanges consistent with impaired oxidative phosphorylation. Hepatology, 2010,51（1）:227-236.
[14] Su YW,Chen X,Jiang ZZ,et al. A panel of serum microRNAs as specificbiomarkers for diagnosis of compound-and herb-induced liver injury in rats. PLoS One,2012,7（5）:e37395.
[15] Bala S,Petrasek J,Mundkur S,et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced,and inflammatory liver diseases. Hepatology,2012,56（5）:1946-1957.
[16] Antoine DJ,Dear JW,Lewis PS,et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.Hepatology,2013,58（2）:777-787.
[17] Watkins PB,Desai M,Berkowitz SD,et al. Evaluation of drug-induced serious hepatotoxicity（eDISH）:application of this dataorganization approach to phase III clinical trials of rivaroxabanafter total hip or knee replacement surgery. Drug Saf, 2011, 34（3）:243-252.

Biomarkers in drug-induced liver injuries

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[2]	Huang Chunyang, Shan Jing, Liao Huiyu, Huang Yunli, Han Ying, Zhang Xiaodan, Du Xiaofei, Ren Meixin, Bian Xinqu, Liu Yanmin. Clinical and laboratory characteristics of patients with drug-induced liver injury receiving glucocorticoid therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 208-211.
[3]	Wu Xiuxin, Zhang Huiyong, Zhang Kai. Changes of plasma microRNA-4284 in patients with anti-tuberculosis drug-induced hepatotoxicity [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 212-215.
[4]	Sun Wenjing, Chen Dongfeng.. Literature analysis about RUCAM scale and Maria scale in diagnosis of Chinese patients with drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 881-884.
[5]	Tong Xin, Fan Hua. Efficacy of bicyclic alcohol on liver function in gastric cancer patients with chemotherapy-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 625-626.
[6]	Liu Cong, Wang Tingting, Zuo Lili, et al. Analysis of patients with drug-induced liver injury in recent 3 years [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 639-640.
[7]	Liu Liangyi, Su Dongyuan. Comparison of clinical and liver pathological features of patients with drug-induced liver injury and autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 463-464.
[8]	Wei Lujia, Li Qingxiang, Ji Qingwei.. Clinical features of amiodarone-induced acute liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 424-426.
[9]	Zhang Dai，Wang Bingyuan.. Novel medicines, new members of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 129-131.
[10]	Wang Yuxia，Du Jian.. Diagnostic and therapeutic progress in anti-thyroid drug -induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 135-138.
[11]	Zheng Kai，Li Hai.. Hepatotoxicity of lipid-lowering agents [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 139-141.
[12]	Zhou Xueshi，Yin Cuilan，Lu Zhonghua，et al.. Drug-induced liver injury：a report of two cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 250-251.
[13]	Lei Wei，Wang Dandan，Ge Guangb，et al.. Serum biomarkers of liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 252-254.
[14]	Du Shuixian, Lu Linlin, Miao Yingxia, et al.. Features of children with drug-induced liver injury:An analysis of 34 cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 607-609.
[15]	Yao Yunjie, Xiao Lang, Yang Caixing, et al. Clinical and pathological features of patients with Chinese herbal drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 441-444.